SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-24-000807
Filing Date
2024-05-15
Accepted
2024-05-15 16:15:10
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e5659_10q.htm   iXBRL 10-Q 1410693
2 EXHIBIT 31.1 e5659_ex31-1.htm EX-31.1 8573
3 EXHIBIT 31.2 e5659_ex31-2.htm EX-31.2 8635
4 EXHIBIT 32.1 e5659_ex32-1.htm EX-32.1 5041
5 EXHIBIT 32.2 e5659_ex32-2.htm EX-32.2 5036
  Complete submission text file 0001731122-24-000807.txt   7401312

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE renb-20240331.xsd EX-101.SCH 63143
7 XBRL CALCULATION FILE renb-20240331_cal.xml EX-101.CAL 52072
8 XBRL DEFINITION FILE renb-20240331_def.xml EX-101.DEF 269061
9 XBRL LABEL FILE renb-20240331_lab.xml EX-101.LAB 465943
10 XBRL PRESENTATION FILE renb-20240331_pre.xml EX-101.PRE 411625
77 EXTRACTED XBRL INSTANCE DOCUMENT e5659_10q_htm.xml XML 1055603
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 24950901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)